If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStaffline Regulatory News (STAF)

Share Price Information for Staffline (STAF)

Share Price is delayed by 15 minutes
Get Live Data
39.00    1.00 (2.63%)
Bid:
38.00
Ask:
39.00
Spread: 1.00 (2.632%)
Market Cap: £42.67m
STAF Live PriceLast checked at - London Stock Exchange

Intraday Staffline Share Chart

Statement re GLA announcement

25 Nov 2009 15:45

RNS Number : 0887D
Staffline Group PLC
25 November 2009
 



GLA to revoke the licenses of labour providers operating non-compliant travel and subsistence schemes

Staffline, a leading provider of recruitment and outsourced HR services to industry, notes that the Gangmasters Licensing Authority (GLA) has today announced that, with effect from 17 February 2010, it will normally revoke the licenses of any licence holders using salary sacrifice schemes which breach the following licensing standards:

the requirement to pay national minimum wage;

the prohibition of work-finding fees; and

the requirement to accurately calculate and pay tax and National Insurance.

In respect of these, the GLA has issued guidance that 

expenses paid to workers do not count towards wages;

compulsory 'administration feeslevied on workers in relation to travel schemes are non-compliant in the absence of the provision of additional services; and

labour providers are required to provide evidence that tax free expenses have actually been incurred by workers and providers can not apply HMRC dispensations granted to other license holders or employers. 

Where non compliance is proven, in addition to action from the GLA, HMRC will take action to seek arrears of tax, national insurance and national minimum wage. Penalties and interest will also be sought were appropriate. 

Staffline estimates that the overall cost to the Treasury of the continued use of this loophole, by both regulated and non-regulated sectors, is approximately £0.5bn; this latest development from the GLA will only go some way to address the regulated sector. 

The GLA has developed its stance as a response to the increasingly prevalent use of salary sacrifice schemes, where workers are encouraged to sacrifice a proportion of their wages in relation to expenses such as travel and subsistence costs, the aim being to reduce the amount of income tax and national insurance contributions payable by both workers and employersThe GLA has recently seen cases where minimum wage workers have had over 50% of their pay attributed to expenses, leaving their actual salary and the taxable amount as low as £97 per week. This reduction in an employee's national insurance contributions can leave employees unable to access contributory tax benefits, such as pensions, Jobseeker's Allowance and Employment and Support Allowance if their contributions in the years preceding a claim are insufficient.

Commenting, Andy Hogarth, Staffline's Chairman and Chief Executive, said:

"We welcome today's announcement from the GLA, which further highlights the misuse of salary sacrifice schemes to undercut those not using the schemes and is an encouraging step towards ensuring workers receive the wages and benefits that they are due."

- Ends -

For further information, please contact:

www.staffline.co.uk

Staffline Group plc

0115 950 0885

Andy Hogarth, Chairman and Chief Executive

07931 175775

Marshall Evans, Operations Director

07931326764

Smithfield

Katie Hunt

Rebecca Whitehead 

020 7360 4900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPUGCCGUPBGAA
Date   Source Headline
29th Mar 20236:07 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirectorate Change
27th Mar 20232:34 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSHolding(s) in Company
21st Mar 20237:00 amRNS2022 Audited Results
8th Mar 20237:00 amRNSAnalyst & Investor Presentation
1st Mar 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20234:43 pmRNSDirector/PDMR Shareholding
20th Feb 202312:48 pmRNSEBT Share Purchase
17th Feb 20237:01 amRNSDirector/PDMR Shareholding
17th Feb 20237:00 amRNSGrant of Options under 2023 LTIP
13th Feb 202310:50 amRNSReplacement: Director/PDMR Shareholding
10th Feb 202312:25 pmRNSDirector/PDMR Shareholding
10th Feb 20237:00 amRNSDirector/PDMR Shareholding
8th Feb 20237:20 amRNSDirector/PDMR Shareholding
6th Feb 20234:40 pmRNSSecond Price Monitoring Extn
6th Feb 20234:35 pmRNSPrice Monitoring Extension
2nd Feb 20232:01 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSDirector/PDMR Shareholding
26th Jan 20233:45 pmRNSEBT Share Purchase
26th Jan 202311:59 amRNSDirector/PDMR Shareholding
25th Jan 202311:28 amRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSTrading Update & Notice of Results
19th Jan 20237:00 amRNSAppointment of Joint Broker
13th Jan 20237:00 amRNSNotice of Trading Update & Investor Presentation
23rd Dec 20229:44 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSBoard Update
11th Nov 202210:18 amRNSDirector/PDMR Shareholding
9th Nov 20224:26 pmRNSGrant of Options under SAYE Scheme
31st Oct 202212:00 pmRNSDirector/PDMR Shareholding
18th Oct 20225:04 pmRNSDirector/PDMR Shareholding
10th Oct 202210:20 amRNSEBT Share Purchase
3rd Oct 20224:53 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:03 amRNSDirector Declaration
27th Sep 20222:06 pmRNSDirector/PDMR Shareholding
18th Aug 20222:26 pmRNSDirector/PDMR Shareholding
15th Aug 202210:04 amRNSDirector/PDMR Shareholding
11th Aug 20227:01 amRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirector/PDMR Shareholding
9th Aug 202211:21 amRNSTotal Voting Rights
9th Aug 202211:20 amRNSHolding(s) in Company
9th Aug 20227:00 amRNSDirector/PDMR Shareholding
3rd Aug 20226:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20226:18 pmRNSEBT Share Purchase
2nd Aug 20227:01 amRNSNew Contract Win
2nd Aug 20227:00 amRNSUnaudited Interim Results
13th Jul 20227:00 amRNSNotice of Results and Investor Presentation
5th Jul 20225:38 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.